Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Inside Precision Medicine recently featured an article describing a study that was published in the European journal Diabetologia conducted by a team of Chinese and Swedish researchers. The study suggested…
Continue ReadingNew Study Highlights a Protein With the Potential to Predict Cancer Deaths and Type 2 Diabetes Risk
Results of a recent study published in Medscape Medical News assessed the effect of treatment with radiotherapy on patients who have prostate cancer that is localized. Statistics show that…
Continue ReadingProstate Cancer: Exploring the Risk of Prostate Radiotherapy
According to a recent article in the British publication Latest Page News, doctors at the University College in London and Royal Free London believe that a ‘cure’ is possible within…
Continue ReadingBritish Researchers Announce Positive Results from New Study of Potentially Curative Treatment for Hemophilia Patients
Rare Disease Diagnoses Get a Boost from Scientists’ New guidelines Professor Dame Sue Hill, Chief Scientific Officer of NHS England, recently interviewed with MedicalXpress citing the importance of unraveling the mystery…
Continue ReadingRare Disease Diagnoses Get a Boost from Scientists’ New Guidelines
This is Jason’s story as told to Memorial Sloan Kettering’s “In The News”. Jason Mascolo at 34 years of age had been living with constant leg pain for years. However,…
Continue ReadingThis Sarcoma Patient Calls it a Cancer Miracle. The Doctor Calls it Immunotherapy
Researchers acknowledge that the primary cause of failure of stem cell transplants is disease relapse. This holds true specifically for allogeneic hematopoietic stem cell transplants where a cancer patient…
Continue ReadingExperimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John Hornsby Sr., a native of Kentucky, suffered for six months with what he thought was a hernia. John was wrong. He had incurable Non-Hodgkin’s follicular lymphoma, and surgery…
Continue ReadingA New Lifesaving Treatment for Follicular Lymphoma
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…
Continue ReadingCompassion Corner: Balancing Compassion with Objectivity; Benefits to Patients and Doctors
Fibrodysplasia ossificans progressiva (FOP) begins with very little warning. When children are born with FOP, they appear normal aside from a possibly characteristic malformation of the largest toe that…
Continue ReadingFibrodysplasia Ossificans Progressiva: A Rare Disease That Turns The Body Into Bone
Although many people in the United States face challenges when seeking healthcare services, new research has found that when seeking a diagnosis for a rare disease, the situation is…
Continue ReadingPeople Living With a Rare Disease Need Better Healthcare
The Catawba Virginia Farmers Market’s mission is to provide the Catawba community with local produce and handicrafts. Stephanie and Donald Schneider owners of Pacaberry Farms have been vendors at the…
Continue ReadingTheir Daughter’s Diagnosis: Ataxia-Telangiectasia. The Treatment: Physical Therapy, Medication, and Love
Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…
Continue ReadingICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
Scientists have known for years that Wiskott-Aldrich syndrome (WAS) is caused by a gene on the X chromosome. The gene (the WASP gene) can be found throughout the immune…
Continue ReadingResearchers Discover a Therapeutic Target for Wiskott-Aldrich Syndrome
Takeda and its collaborator, Arrowhead Pharmaceuticals, recently announced results from AROAAT-2002 of the investigational drug fazirsiran. The drug is an RNA interference therapeutic developed to lessen alpha-1 antitirypsin protein…
Continue ReadingResults From This Study are Encouraging for Alpha-1 Antitrypsin Deficiency Liver Disease
Danielle Morley of Radcliffe, UK, has been an advocate for plasma donation ever since being diagnosed with a rare blood disorder called immune thrombocytopenic purpura (ITP) during her first…
Continue ReadingImmunoglobulin Saved Her Life and Gave Life to Her Three Children
As time runs out, volunteer Dominic Gillen is running even harder. In an interview with KETV, he admits that they are not yet where they should be in order…
Continue ReadingNebraskans for Medical Marijuana Are Running Out of Time to Put Petitions on the Ballot Before November
CBC News Canada carried the story of a 23-year-old patient, Morgan Buyaki of Saskatchewan, Canada, who was diagnosed eighteen months ago with eosinophilic granulomatosis with polyangiitis (EGPA). Morgan’s mother…
Continue ReadingA Mother’s Last Hope to Save Her Daughter’s Life
The most common form of leukemia in Western countries is chronic lymphocytic leukemia (CLL). The disease accounts for almost thirty percent of known leukemia cases. Approximately 30,000 Europeans were…
Continue ReadingZanubrutinib Superior to Ibrutinib in Advanced CLL
A recent article at Healio Rheumatology highlights a presentation given by Dr. Arthur Kavanaugh of the University of California to attendees at the 2022 Clinical Rheumatology Congress East. Dr. Kavanaugh…
Continue ReadingA Growing List of Options for Psoriatic Arthritis Patients
Tuberous sclerosis complex (TSC) is classified as a rare genetic disorder that causes typically benign tumors in the brain, skin, heart, kidneys, or lungs. As described in a recent article…
Continue ReadingResearchers Created Mini-Kidneys to Identify Tuberous Sclerosis Complex and Solve a Medical Mystery
According to a press release by Merck & Co. issued on June 24, the European Commission has approved the use of adjuvant Pembrolizumab to treat resected stage IIB/C melanoma. "Adjuvant"…
Continue ReadingThe European Commission Has Approved Pembrolizumab (Keytruda) to Treat Resected Stage IIB and IIC Melanoma
A study of hereditary angioedema (HAE) patients in Brazil was featured in an article in the Angioedema News. Researchers found that patients waited on average seventeen years for a…
Continue ReadingPatients in Brazil Wait Decades for a Hereditary Angioedema Diagnosis
The history of mesothelioma dates back to 1767 as being the earliest record of tumors found on the lining of the lungs. In 1909 J.G. Adami introduced the term…
Continue ReadingMesothelioma: A Study of T-Cell Infiltration As the Disease Evolves
Findings from the MITO23 Trial investigating the outcome of the chemotherapy drug trabectedin against physician’s choice to treat BRCA-mutated patients with ovarian cancer were presented at ASCO’s 2022 Annual…
Continue ReadingICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint
The patient, age 82, had recovered from a stroke several months ago. According to a recent article reported on dnyuz.com and originally published in the New York Times, the…
Continue ReadingICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.